Skip to main content

We’ve updated our Terms & Conditions and Privacy Policy. By using this site, you agree to these terms.

Geisinger becomes the first member of Risant Health

ADMI mission & vision

Mission
To improve outcomes for individuals with developmental disorders and their families through increased access, accurate diagnosis, discovery of underlying causes, and development of targeted treatments. 

Vision
Establish ADMI as a self-sustaining, transdisciplinary clinical and research institute and an international leader known for advancing the scientific understanding of developmental disorders. In partnership with families, our goal is to leverage new scientific discoveries to transform our understanding of the causes and treatments of these conditions.

 A message from our Director:

15% of children are diagnosed with a developmental disorder. We want to be game changers in the lives of our patients and their families by creating a seamless integration of clinical care and innovative research. To do so, we’ve brought together an unparalleled team of experts to focus on improving outcomes through cutting-edge research.

Our team includes board-certified Neurodevelopmental Pediatricians, a board-certified Developmental-Behavioral Pediatrician, board-certified Medical Geneticists, board-certified Genetic Counselors, licensed Psychologists, and a certified and licensed Speech-Language Pathologists. With such an extraordinary combination of specialties, we’re changing the approach to how developmental disorders are diagnosed, managed, and treated. We don’t just focus on one aspect of a person’s care – we treat the whole individual – from a medical, behavioral, and genetics perspective.

As part of a learning health system, our research also brings together complementary areas of expertise to explore the underpinnings of developmental disorders. Our investigators combine neuroimaging, developmental medicine, psychology, genomics, and high-performance computing to delve into the causes of developmental disorders with a goal of discovering new therapies and ultimately cures. 

Christa Lese Martin
Christa Lese Martin, PhD
Content from General Links with modal content